322 related articles for article (PubMed ID: 26014946)
1. A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.
Carlier M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4689-94. PubMed ID: 26014946
[TBL] [Abstract][Full Text] [Related]
2. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
[TBL] [Abstract][Full Text] [Related]
3. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
[TBL] [Abstract][Full Text] [Related]
4. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.
De Waele JJ; Lipman J; Akova M; Bassetti M; Dimopoulos G; Kaukonen M; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Udy AA; Starr T; Wallis SC; Roberts JA
Intensive Care Med; 2014 Sep; 40(9):1340-51. PubMed ID: 25053248
[TBL] [Abstract][Full Text] [Related]
6. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
7. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
[TBL] [Abstract][Full Text] [Related]
9. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
[TBL] [Abstract][Full Text] [Related]
10. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Antibiotics in Sub-Saharan African Patient Populations: A Systematic Review.
Bos JC; van Hest RM; Prins JM
Ther Drug Monit; 2017 Aug; 39(4):387-398. PubMed ID: 28703719
[TBL] [Abstract][Full Text] [Related]
12. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
[TBL] [Abstract][Full Text] [Related]
13. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
[TBL] [Abstract][Full Text] [Related]
14. A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients.
Abdulla A; Ewoldt TMJ; Purmer IM; Muller AE; Gommers D; Endeman H; Koch BCP
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):359-368. PubMed ID: 33463382
[TBL] [Abstract][Full Text] [Related]
15. Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment.
Chiriac U; Frey OR; Roehr AC; Koeberer A; Gronau P; Fuchs T; Roberts JA; Brinkmann A
Medicine (Baltimore); 2021 Jun; 100(22):e26253. PubMed ID: 34087915
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy.
Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I
Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2171-2175. PubMed ID: 30120647
[TBL] [Abstract][Full Text] [Related]
18. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
Fuchs A; Li G; van den Anker JN; Bielicki J
Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
[TBL] [Abstract][Full Text] [Related]
19. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
